<DOC>
	<DOCNO>NCT00492076</DOCNO>
	<brief_summary>The purpose study determine whether short course subcutaneous immunotherapy efficacious mite induce asthma . The efficacy base reduction control medication .</brief_summary>
	<brief_title>Efficacy Safety Trial Subcutaneous Immunotherapy Mite Induced Asthma</brief_title>
	<detailed_description>The control mild-moderate persistent asthma include need concomitant medication , inhaled corticosteroid . However , compliance perennial asthma low . The aim study assess possibility reduce need concomitant medication short-course subcutaneous immunotherapy .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Mild/moderate persistent asthma Positive skin prick test specific IgE mites Age : 1455 year old Immunotherapy contraindication Allergy inhalant allergens Previous immunotherapy ( 5 year ) mite</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Specific immunotherapy</keyword>
	<keyword>Mite</keyword>
	<keyword>Asthma</keyword>
</DOC>